Showing 49 to 54 of 54 results
NHS to Trial Non-Invasive Brain-Computer Interface for Neurological and Psychiatric Disorders
The UK's NHS is funding a £6.5 million trial of a non-invasive brain-computer interface using ultrasound to treat neurological and psychiatric conditions; 30 patients with existing skull defects will test the device's safety and ability to improve mood and motivation.
NHS to Trial Non-Invasive Brain-Computer Interface for Neurological and Psychiatric Disorders
The UK's NHS is funding a £6.5 million trial of a non-invasive brain-computer interface using ultrasound to treat neurological and psychiatric conditions; 30 patients with existing skull defects will test the device's safety and ability to improve mood and motivation.
Progress
40% Bias Score
World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...
World-First Personalized mRNA Cancer Vaccine Shows Promise in Treating Urinary Tract Cancer
A 75-year-old woman at Bari's Policlinico hospital became the first globally to receive a personalized mRNA cancer vaccine (cevumeran) alongside nivolumab immunotherapy after surgery for high-risk urinary tract cancer; this innovative treatment is designed to address specific tumor mutations, offeri...
Progress
56% Bias Score
NIH Study Investigates Impact of Ultra-Processed Foods
A clinical trial at the NIH is studying the effects of ultra-processed foods on weight gain and health, with potential implications for US dietary guidelines.
NIH Study Investigates Impact of Ultra-Processed Foods
A clinical trial at the NIH is studying the effects of ultra-processed foods on weight gain and health, with potential implications for US dietary guidelines.
Progress
40% Bias Score
Mosquito-Delivered Malaria Vaccine Shows 89% Success in Small Trial
Dutch researchers successfully used genetically modified mosquitoes to deliver a malaria vaccine, achieving an 89% success rate in a small trial with the GA2 vaccine; larger studies are needed to confirm efficacy and long-term immune response.
Mosquito-Delivered Malaria Vaccine Shows 89% Success in Small Trial
Dutch researchers successfully used genetically modified mosquitoes to deliver a malaria vaccine, achieving an 89% success rate in a small trial with the GA2 vaccine; larger studies are needed to confirm efficacy and long-term immune response.
Progress
36% Bias Score
High-Dose Vitamin C Doubles Survival Rate in Pancreatic Cancer Study
A phase 2 clinical trial at the University of Iowa Health Care found that adding 75 grams of intravenous vitamin C three times a week to chemotherapy for late-stage pancreatic cancer doubled overall survival rates to 16 months and increased progression-free survival to six months.
High-Dose Vitamin C Doubles Survival Rate in Pancreatic Cancer Study
A phase 2 clinical trial at the University of Iowa Health Care found that adding 75 grams of intravenous vitamin C three times a week to chemotherapy for late-stage pancreatic cancer doubled overall survival rates to 16 months and increased progression-free survival to six months.
Progress
40% Bias Score
New Mpox Vaccine Trial in Kenya
Kenya and US partner to trial new mpox vaccine amid surge in African cases.
New Mpox Vaccine Trial in Kenya
Kenya and US partner to trial new mpox vaccine amid surge in African cases.
Progress
0% Bias Score
Showing 49 to 54 of 54 results